234 related articles for article (PubMed ID: 23164935)
21. Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery.
Catuogno S; Esposito CL; Giangrande PH
Methods Mol Biol; 2021; 2282():31-42. PubMed ID: 33928568
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNA.
Zhu Q; Shibata T; Kabashima T; Kai M
Eur J Med Chem; 2012 Oct; 56():396-9. PubMed ID: 22907035
[TBL] [Abstract][Full Text] [Related]
23. Rabies Prophylactic and Treatment Options: An In Vitro Study of siRNA- and Aptamer-Based Therapeutics.
Scott TP; Nel LH
Viruses; 2021 May; 13(5):. PubMed ID: 34064911
[TBL] [Abstract][Full Text] [Related]
24. Photomodulating Gene Expression by Using Caged siRNAs with Single-Aptamer Modification.
Zhang L; Chen C; Fan X; Tang X
Chembiochem; 2018 Jun; 19(12):1259-1263. PubMed ID: 29488297
[TBL] [Abstract][Full Text] [Related]
25. Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1.
Dey AK; Griffiths C; Lea SM; James W
RNA; 2005 Jun; 11(6):873-84. PubMed ID: 15923374
[TBL] [Abstract][Full Text] [Related]
26. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
Bolhassani A; Milani A
Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
[TBL] [Abstract][Full Text] [Related]
27. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
[TBL] [Abstract][Full Text] [Related]
28. Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2.
Wullner U; Neef I; Eller A; Kleines M; Tur MK; Barth S
Curr Cancer Drug Targets; 2008 Nov; 8(7):554-65. PubMed ID: 18991566
[TBL] [Abstract][Full Text] [Related]
29. UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C.
Mufhandu HT; Gray ES; Madiga MC; Tumba N; Alexandre KB; Khoza T; Wibmer CK; Moore PL; Morris L; Khati M
J Virol; 2012 May; 86(9):4989-99. PubMed ID: 22379083
[TBL] [Abstract][Full Text] [Related]
30. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy.
Kruspe S; Giangrande PH
Methods Mol Biol; 2017; 1632():175-186. PubMed ID: 28730439
[TBL] [Abstract][Full Text] [Related]
31. Effective inhibition of HIV-1 production by short hairpin RNAs and small interfering RNAs targeting a highly conserved site in HIV-1 Gag RNA is optimized by evaluating alternative length formats.
Scarborough RJ; Adams KL; Daher A; Gatignol A
Antimicrob Agents Chemother; 2015 Sep; 59(9):5297-305. PubMed ID: 26077260
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
[TBL] [Abstract][Full Text] [Related]
33. A Hitchhiker's guide to HIV.
Yan A; Ellington A
Mol Ther; 2008 Aug; 16(8):1356-8. PubMed ID: 18660800
[No Abstract] [Full Text] [Related]
34. Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
Dave RS; Pomerantz RJ
J Virol; 2004 Dec; 78(24):13687-96. PubMed ID: 15564478
[TBL] [Abstract][Full Text] [Related]
35. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
Sivakumar P; Kim S; Kang HC; Shim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.
Wheeler LA; Trifonova R; Vrbanac V; Basar E; McKernan S; Xu Z; Seung E; Deruaz M; Dudek T; Einarsson JI; Yang L; Allen TM; Luster AD; Tager AM; Dykxhoorn DM; Lieberman J
J Clin Invest; 2011 Jun; 121(6):2401-12. PubMed ID: 21576818
[TBL] [Abstract][Full Text] [Related]
37. Aptamer mediated siRNA delivery.
Chu TC; Twu KY; Ellington AD; Levy M
Nucleic Acids Res; 2006 Jun; 34(10):e73. PubMed ID: 16740739
[TBL] [Abstract][Full Text] [Related]
38. An aptamer-siRNA chimera silences the eukaryotic elongation factor 2 gene and induces apoptosis in cancers expressing αvβ3 integrin.
Hussain AF; Tur MK; Barth S
Nucleic Acid Ther; 2013 Jun; 23(3):203-12. PubMed ID: 23544955
[TBL] [Abstract][Full Text] [Related]
39. Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy.
Chung J; Zhang J; Li H; Ouellet DL; DiGiusto DL; Rossi JJ
Hum Gene Ther; 2012 Nov; 23(11):1200-8. PubMed ID: 22834872
[TBL] [Abstract][Full Text] [Related]
40. Method for Confirming Cytoplasmic Delivery of RNA Aptamers.
Dickey DD; Thomas GS; Dassie JP; Giangrande PH
Methods Mol Biol; 2016; 1364():209-17. PubMed ID: 26472453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
